Don't use the word 'lynching'; it defames India: RSS Chief Bhagwat

News Network
October 8, 2019

Nagpur, Oct 8: Rashtriya Swayamsevak Sangh (RSS) chief Mohan Bhagwat on Tuesday said lynching is a "western construct" and should not be used in the Indian context. According to him the word “lynching” defames India.

Addressing the Vijayadashmi function of the RSS at Reshimbagh ground in Maharashtra's Nagpur city, he said the word 'lynching' does not originate from Indian ethos but comes from a separate religious text, and such terms should not be imposed on Indians.

He also lauded Prime Minister Narendra Modi and Union Home Minister Amit Shah over the government's move to abrogate Article 370 in Jammu and Kashmir, but said some vested interests do not want the country to be strong and vibrant.

Voicing his displeasure over several incidents of mob violence in the country, he said, "Lynching is not the word from Indian ethos, its origin is from a story in a separate religious text. We Indians trust in brotherhood. Don't impose such terms on Indians."

"Lynching itself is a western construct and one shouldn't use it in the Indian context to defame the country," he said.

Bhagwat urged citizens to create harmony, and that everyone should live within confines of the law. "Swayamsevaks are brought up with that sanskar," he said.

He said in the past few years, there has been a transformation in "direction of the thought process of Bharat".

"There are many people in the world and in Bharat as well, who don't want this. A developed Bharat creates fear in the minds of vested interests...such forces will also not want Bharat to be strong and vibrant," the RSS chief said.

Even well-meaning policies, statements from persons in government and administration were being misused to benefit nefarious designs by vested interests, he rued.

"We must be alert in identifying these plots and counter them on intellectual and social levels," he said.

Bhagwat said the world was eager to know if the 2019 elections in such a huge country will be conducted smoothly.

"Democracy in India is not something imported from any country, but a practice which has been prevalent here since centuries," Bhagwat said.

He said India's borders were now safer than ever, and more focus was needed on coastal security.

"The number of guards and check-posts on land borders and surveillance along the maritime border, especially on islands, have to be increased," he said.

On concerns over the economic sector, he said the slowing down of the world economy has left its impact everywhere.

"The government has taken initiatives to tide over the situation in the last one-and-a-half months. Our society is entrepreneurial and will overcome these challenges," he added.

In the morning, Bhagwat performed 'shastra puja' at the Sangh's annual Vijayadashmi event here.

HCL founder Shiv Nadar was the chief guest for this year's event.

Union ministers Nitin Gadkari, Gen V K Singh (retd) and Maharashtra Chief Minister Devendra Fadnavis were among those present at the event. 
 

Comments

sam
 - 
Tuesday, 8 Oct 2019

the word "सार्वजनिक हत्या" - would satisfy chaddi people

ahmed ali k
 - 
Tuesday, 8 Oct 2019

This person is not advising his followers not to do this type of shameful act which defames India instead it seems he is supporting his followers to do such act and asking the public to not to use the word "Lynching" and use some other word for the same act.

Shame on you man..........!!!!

 

A stigma to society

mohammed
 - 
Tuesday, 8 Oct 2019

what about pinching..

Jameel
 - 
Tuesday, 8 Oct 2019

Yes. Lynching is an English word. for you, uneducated goons its better you use "murdering"

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 3,2020

Jun 3: Emphasising that airlines are clearly the safest mode of transportation, IndiGo CEO Ronojoy Dutta on Tuesday said there is no evidence yet of coronavirus infection getting transmitted among passengers onboard an aeroplane.

His comments against the backdrop of instances of some passengers, who had taken flights after resumption of domestic air services on May 25, testing positive for coronavirus.

"Those people had the virus before they got on to the aeroplane. What is noteworthy is that they have done the tracing after that. There is no evidence of transmission onboard there... that is a very encouraging sign on the safety of airline travel," he said during an earnings call.

According to him, airlines are clearly the safest mode of transportation and there is no evidence yet of contamination on an aircraft.

"You can come in contaminated but so far there is no evidence of passing it on to a fellow passenger," he noted.

Amid concerns over the coronavirus pandemic, aviation regulator DGCA has asked airlines to ensure that to the extent possible, middle seat in flights should be kept empty.

In this regard, Dutta said the airline would keep the middle seat empty wherever it can and "where we have to fill the middle seat, we will have the extra protective gown".

To a query about possible hedging of fuel prices, he said it would be a dumb idea and that airlines adjust to ups and downs in fuel prices.

"I can't overemphasise what a dumb idea it will be for an airline to hedge fuel prices. I looked at it from different angles and it is not a good idea... we looked at hedging and we talked about it at the board level and we said no," he noted.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 15,2020

New Delhi, Jun 15: On Monday, petrol and diesel prices across the country were raised for the ninth consecutive day by 48 paise and 59 paise, respectively.

Petrol price per litre was raised to Rs 76.26 in New Delhi, Rs 83.17 in Mumbai, Rs 79.96 in Chennai, Rs 79.17 in Hyderabad, Rs 78.73 in Bengaluru and Rs 78.10 in Kolkata.

Diesel price per litre was hiked to Rs 74.62 in New Delhi, Rs 73.21 in Mumbai, Rs 72.69 in Chennai, Rs 72.93 in Hyderabad, Rs 70.95 in Bengaluru and Rs 70.33 in Kolkata.

Since 7 June, after ending their 82-day hiatus in daily revision, state-owned oil marketing companies have increased petrol price by Rs 5 per litre and diesel by Rs 5.23 per litre.

These prices are close to levels last seen in October-November 2018 when international oil prices had spiked close to $80 per barrel. In October 2018, petrol price in Mumbai had crossed Rs 90-mark and in Delhi, it was around Rs 83 per litre.

Comparatively, on Monday, Brent crude, the international benchmark for crude oil prices, fell 2.3 percent to $37.84 a barrel over concerns of subdued demand for fuel as new coronavirus infections were reported in China and the US.

The present spike in fuel prices in India could be attributed to the fact that central and state governments, along with oil marketing companies are looking to make up for their loss in revenues due to the lockdown.

Last month, the central government had increased the excise duty on per litre of petrol by Rs 10 and per litre of diesel by Rs 13. Several state governments have also hiked their VAT or cess on fuel in the last month. In fact, now around 70 percent of the retail price of fuel is just some form of tax.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.